BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2215 related articles for article (PubMed ID: 12001118)

  • 21. A comparison of early (E7) and late (L1) primer-mediated amplification of papillomaviral DNA in cervical neoplasia.
    Tate JE; Yang YC; Shen J; McLachlin CM; Sheets EE; Crum CP
    Mol Cell Probes; 1996 Oct; 10(5):347-51. PubMed ID: 8910889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
    Jiang M; Milner J
    Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.
    Halfon P; Benmoura D; Agostini A; Khiri H; Martineau A; Penaranda G; Blanc B
    J Clin Virol; 2010 Feb; 47(2):177-81. PubMed ID: 20022804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay.
    Dixon EP; King LM; Adams MD; Grønn P; Murphy PG; Brown CA; Brough GH; Skomedal H; Malinowski DP; Fischer TJ
    J Virol Methods; 2008 Dec; 154(1-2):220-2. PubMed ID: 18761379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of E6/E7 transcription patterns in HPV 16-positive cervical cancers using the reverse transcription/polymerase chain reaction.
    Rose BR; Thompson CH; Tattersall MH; Elliott PM; Dalrymple C; Cossart YE
    Gynecol Oncol; 1995 Feb; 56(2):239-44. PubMed ID: 7896192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of human papillomavirus DNA in cervical squamous cell carcinoma in Xinjiang Uygur women].
    Suzuk L; Noffsinger AE; Aili M
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):405-8. PubMed ID: 9639725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
    Sasagawa T; Basha W; Yamazaki H; Inoue M
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of human papillomavirus type 16 E6/E7 transcripts in histologically cancer-free pelvic lymph nodes of patients with cervical carcinoma.
    Rose BR; Thompson CH; Jiang XM; Tattersall MH; Elliott PM; Dalrymple C; Cossart YE
    Gynecol Oncol; 1994 Feb; 52(2):212-7. PubMed ID: 8314141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus DNA is present in a subset of unselected breast cancers.
    Liu Y; Klimberg VS; Andrews NR; Hicks CR; Peng H; Chiriva-Internati M; Henry-Tillman R; Hermonat PL
    J Hum Virol; 2001; 4(6):329-34. PubMed ID: 12082399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
    Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
    J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytic sensitivities of hybrid-capture, consensus and type-specific polymerase chain reactions for the detection of human papillomavirus type 16 DNA.
    Cavuslu S; Mant C; Starkey WG; Bible JM; Biswas C; Kell B; Rice P; Best JM; Cason J
    J Med Virol; 1996 Aug; 49(4):319-24. PubMed ID: 8877765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
    Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
    Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
    J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of human papillomavirus type 16 E6/E7 mRNA in cervical cancers and precancerous lesions by means of the polymerase chain reaction with reverse transcriptase reaction].
    Nishikawa A; Shimada M; Fukushima M
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1660-6. PubMed ID: 1720801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 111.